CCL2 and hepatocellular carcinoma: In addition, CCL2 in hepatocellular carcinoma (HCC) models attracts CCR2+ myeloid cells that stimulate SC clearance via immunosurveillance but can promote the growth of already established HCC cells by inhibiting NK cell–mediated clearance of cancer cells (115).